FDG-PET is superior to gallium scintigraphy in staging and more sensitive in the follow-up of patients with de novo Hodgkin lymphoma: a blinded comparison. (Q53626814)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | FDG-PET is superior to gallium scintigraphy in staging and more sensitive in the follow-up of patients with de novo Hodgkin lymphoma: a blinded comparison. |
scientific article |
Statements
FDG-PET is superior to gallium scintigraphy in staging and more sensitive in the follow-up of patients with de novo Hodgkin lymphoma: a blinded comparison. (English)
Donna Neuberg
Jonathan W Friedberg
Alan Fischman
Helen Kim
Tak Takvorian
Andrea K Ng
Peter M Mauch
George P Canellos
Annick D van den Abbeele
1 January 2004
45
1
85-92
1 reference
1 reference
1 reference
1 reference
1 reference